Filing Flows › TransMedics Group (TMDX) › Recalls, complaints & regulation
TransMedics Group (TMDX): clinical trials
TransMedics Group (TMDX) beyond its filings: 10 active clinical trials.
TransMedics Group's latest quarter
TransMedics Group, Q3 2026: revenue $203M (+41% year over year), operating margin 13.9%, net earnings $17.1M, operating cash flow $36.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does TransMedics Group have?
10 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.